|
1
|
Matsumoto Y, Imai Y, Sugita Y, Tanaka T,
Tsujimoto G, Saito H and Oshida T: CCDC132 is highly expressed in
atopic dermatitis T cells. Mol Med Rep. 3:83–87. 2010.PubMed/NCBI
|
|
2
|
Abramovits W: Atopic dermatitis. J Am Acad
Dermatol. 53:S86–S93. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kurt-Jones EA, Hamberg S, Ohara J, Paul WE
and Abbas AK: Heterogeneity of helper/inducer T lymphocytes. I.
Lymphokine production and lymphokine responsiveness. J Exp Med.
166:1774–1787. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bonness S and Bieber T: Molecular basis of
atopic dermatitis. Curr Opin Allergy Clin Immunol. 7:382–386. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chan LS, Robinson N and Xu L: Expression
of interleukin-4 in the epidermis of transgenic mice results in a
pruritic inflammatory skin disease: an experimental animal model to
study atopic dermatitis. J Invest Dermatol. 117:977–983. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kapp A: The role of eosinophils in the
pathogenesis of atopic dermatitis - eosinophil granule proteins as
markers of disease activity. Allergy. 48:1–5. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kawakami T, Ando T, Kimura M, Wilson BS
and Kawakami Y: Mast cells in atopic dermatitis. Curr Opin Immunol.
21:666–678. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schäfer B, Piliponsky AM, Oka T, Song CH,
Gerard NP, Gerard C, Tsai M, Kalesnikoff J and Galli SJ: Mast cell
anaphylatoxin receptor expression can enhance IgE-dependent skin
inflammation in mice. J Allergy Clin Immunol. 131:541–548. 2013.
View Article : Google Scholar :
|
|
9
|
Tsuruta T, Yamamoto T, Matsubara S,
Nagasawa S, Tanase S, Tanaka J, Takagi K and Kambara T: Novel
function of C4a anaphylatoxin. Release from monocytes of protein
which inhibits monocyte chemotaxis. Am J Pathol. 142:1848–1857.
1993.PubMed/NCBI
|
|
10
|
Zhao Y, Xu H, Yu W and Xie BD: Complement
anaphylatoxin C4a inhibits C5a-induced neointima formation
following arterial injury. Mol Med Rep. 10:45–52. 2014.PubMed/NCBI
|
|
11
|
Jia N, Semba U, Nishiura H, Kuniyasu A,
Nsiama TK, Nishino N and Yamamoto T: Pivotal Advance:
Interconversion between pure chemotactic ligands and
chemoattractant/secretagogue ligands of neutrophil C5a receptor by
a single amino acid substitution. J Leukoc Biol. 87:965–975. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mayr M and Xu Q: Smooth muscle cell
apoptosis in arteriosclerosis. Exp Gerontol. 36:969–987. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Murakami Y, Yamamoto T, Imamichi T and
Nagasawa S: Cellular responses of guinea pig macrophages to C4a;
inhibition of C3a-induced O2-generation by C4a. Immunol Lett.
36:301–304. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nishiura H, Shibuya Y and Yamamoto T: S19
ribosomal protein cross-linked dimer causes monocyte-predominant
infiltration by means of molecular mimicry to complement C5a. Lab
Invest. 78:1615–1623. 1998.
|
|
15
|
Fiorentino DF, Bond MW and Mosmann TR: Two
types of mouse T helper cell. IV. Th2 clones secrete a factor that
inhibits cytokine production by Th1 clones. J Exp Med.
170:2081–2095. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kepron MR, Chen YW, Uhr JW and Vitetta ES:
IL-4 induces the specific rearrangement of gamma 1 genes on the
expressed and unexpressed chromosomes of lipopolysaccharide
activated normal murine B cells. J Immunol. 143:334–339.
1989.PubMed/NCBI
|
|
17
|
Matsumoto M, Ra C, Kawamoto K, Sato H,
Itakura A, Sawada J, Ushio H, Suto H, Mitsuishi K, Hikasa Y and
Matsuda H: IgE hyperproduction through enhanced tyrosine
phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human
atopic dermatitis. J Immunol. 162:1056–1063. 1999.PubMed/NCBI
|
|
18
|
Takakura M, Takeshita F, Aihara M, Xin KQ,
Ichino M, Okuda K and Ikezawa Z: Hyperproduction of IFN-γ by CpG
oligodeoxynucleotide-induce exacerbation of atopic dermatitis-like
skin lesion in some NC/Nga mice. J Invest Dermatol. 125:1156–1162.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tamura T, Amano T, Ohmori K and Manabe H:
The effects of olopatadine hydrochloride on the number of
scratching induced by repeated application of oxazolone in mice.
Eur J pharmacol. 524:149–154. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Simon D, Braathen LR and Simon HU:
Eosinophils and atopic dermatitis. Allergy. 59:561–570. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sanderson CJ, Strath M, Warren DJ, O’Garra
A and Kirkwood TB: The production of lymphokines by primary
alloreactive T-cell clones: a co-ordinate analysis of 233 clones in
seven lymphokine assays. Immunology. 56:575–854. 1985.PubMed/NCBI
|
|
22
|
Bardana EJ Jr: Immunoglobulin E- (IgE) and
non-IgE-mediated reactions in the pathogenesis of atopic
eczema/dermatitis syndrome (AEDS). Allergy. 59(Suppl 78): 25–29.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Monk PN, Scola AM, Madala P and Fairlie
DP: Function, structure and therapeutic potential of complement C5a
receptors. Br J Pharmacol. 152:429–448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie P, Nishiura H, Semba U, Chen J, Zhao
R, Kuniyasu A and Yamamoto T: Inhibitory effects of C4a on
chemoattractant and secretagogue functions of the other
anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway
in mast cells. Int Immunopharmacol. 12:158–168. 2012. View Article : Google Scholar
|
